Abstract:Objective To investigate the clinical phenotype,genotype and molecular mechanism of recurrent venous thrombosis in two Chinese pedigrees with type Ⅰ antithrombin (AT) deficiency.Methods The routine coagulation screening tests were detected,thrombin generation tests was performed to evaluate the hypercoagulation.Anticardiolipin antibody (ACA) and lupus anticoagulant (LA) were detected with enzyme-linked immunosorbent assay (ELISA) and diluted viper venom time assay (DVVT),respectively.The activities of protein C,protein S and AT (PC:A,PS:A,AT:A) were tested with chromogenic substrate assay or clotting method.The antigen of AT ( AT:Ag) was performed with immunoturbidimetry methods.Western blot was used to analyze the molecular weight (MW) and the plasma levels of AT:Ag.All 7 exons and the flanking sequences were amplified by PCR.The mutation of AT gene and thrombophilia associated gene polymorphisms were analyzed by direct DNA sequencing.The expression plasmid of Ala404Asp mutant was constructed with site-directed mutagenesis method based on the wild-type (WT) AT cDNA contained in pcDNA 3.1 vector,and transiently expression of AT WT and the Ala404Asp mutant was performed using HEK293T cells.Cultured supernatant and cell lysates were collected and measured for AT:Ag by ELISA and Western blot.Results The results of routine coagulation tests in two probands were normal,thrombin generation tests indicated that proband 1 presented hypercoagulable state with 2.8 and 1.5 times higher of the endogenous thrombin potential (ETP) and peak height compared with that of normal,respectively.The levels of PC:A,PS:A,ACA and LA were normal.AT:A in proband 1 and proband 2 were 45％ and 32％,and AT:Ag were almost half of the normal ( 121 mg/L and 158 mg/L),respectively.The results of Western blot showed that both probands' plasma levels of AT:Ag were lower than the normal pooled plasma and MW was normal.Two heterozygous mutations of g.3291 C→T( Thr98 Ile),g.13863 C ＞ A (Ala404Asp) were identified in the probands,respectively.No proband had venous thrombosis associated gene polymorphisms.Expression in vitro showed that AT:Ag in culture media and lysates of Ala404Asp are 4.8％ and 60.6％ of that of WT,respectively.Conclusion Thr98Ile and Ala404Asp mutation of AT gene significantly correlate with recurrent venous thrombosis in the two probands,respectively.Ala404Asp has not been described before.The mutant Ala404Asp protein can not be expressed due to impaired secretion and increased intracellular degradation,resulting in type Ⅰ AT deficiency.

Risk of venous thrombosis in antithrombin deficiency: a systematic review and Bayesian meta-analysis

Usefulness of antithrombin deficiency phenotypes for risk assessment of venous thromboembolism: type I deficiency as a strong risk factor for venous thromboembolism

Mild antithrombin deficiency and risk of recurrent venous thromboembolism: results from the MEGA follow-up study

Antipsychotics and Venous Thromboembolism Risk: A Meta-Analysis

Venous thromboembolism risk in adults with hereditary thrombophilia: a systematic review and meta-analysis

Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic …

Incidence and features of thrombosis in children with inherited antithrombin deficiency

Role of factor VIII, IX, and XI in venous thrombosis recurrence risk in adults and children: A systematic review

Molecular Basis and Thrombotic Manifestations of Antithrombin Deficiency in 15 Unrelated Chinese Patients.

Rates of venous thromboembolism and use of thromboprophylaxis after major orthopedic surgery in patients with congenital hemophilia A or B: a systematic review

Antithrombin Activity and Association with Risk of Thrombosis and Mortality in Patients with Cancer

Congenital Thrombophilia in East-Asian Venous Thromboembolism Population: a Systematic Review and Meta-Analysis

Molecular mechanisms of recurrent venous thrombosis in two pedigrees with type Ⅰ antithrombin deficiency

A systematic review and meta-analysis of the incidence of post-thrombotic syndrome, recurrent thromboembolism, and bleeding after upper extremity vein thrombosis

Prevalence of Inherited Antithrombin, Protein C, and Protein S Deficiencies in Portal Vein System Thrombosis and Budd‐Chiari Syndrome: A Systematic Review and Meta‐analysis of Observational Studies

Inherited risk factors for venous thromboembolism

Thrombomodulin gene c.1418C>T polymorphism and risk of recurrent venous thromboembolism

Long-term risk for major bleeding during extended oral anticoagulant therapy for first unprovoked venous thromboembolism: a systematic review and meta-analysis

Antithrombin deficiency: A pediatric disorder

Molecular Basis Of Type I Antithrombin Deficiency In Two Women With Recurrent Venous Thromboembolism In The First Trimester Of Pregnancy

Genetic Analysis Should Be Included in Clinical Practice when Screening for Antithrombin Deficiency